Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Shanghai Henlius Biotech
Condition: Carcinoma of Head and/or Neck
NCT06857279
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: few_sites_large_trial_signal | rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.